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Several studies showed that obesity influences cardiovascular morbidity and mortality. [1] [2] [3] [4] [5] Clinical and necropsy studies on morbid obesity corfirmed the the entity of obese cardiomyopathy, characterised by volume overload and hyperdynamism, 6 frequently leading to congestive heart failure. 7 Studies using echocardiography, cardiac catheterisation, and necropsy examination have shown relations between morbid obesity, structural alterations of the heart, and systolic function. 7 These associations appear to be present even in cases of slight or mild obesity. 8 Sukmoko et al, 9 showed that left ventricular mass was higher in the obese patients compare to normal and there was a correlation between visceral fat and left ventricular mass. Body mass index is a strong determinant of left ventricular hypertrophy 10 and that adipose tissue is a recognized site of cytokine production, in particular interleukin-6 and tumor necrosis factor α, therefore influencing hsCRP level. 10 Obesity is also associated with markers of inflammation 11 and prothrombotic risk.
12,13
Palmieri et al, 14 in the Strong Heart Study reported a relation of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes. However, the correlation between hsCRP and left ventricular mass in obese patients has not been reported.
Our aim in this study was to determine the correlation between hsCRP and left ventricular mass in obese women.
METHODS
We studied 45 obese women and 45 non-obese control women. Obesity was defined as a body mass index (BMI) of > 25 kg/m2, with clear evidence on physical examination of excessive subcutaneous adipose tissue.
Inclusion criteria : no previous history or clinical evidence of coronary artery disease, heart failure, or cardiac valve disease; normal ECG; no connective tissue disease; not suffering from any chronic or acute infection; not taking any drugs that could affect the heart and inflammation. Echocardiographic images had to be of sufficient quality to allow reproducible cross sectional, M-mode and 2-D studies.
All subjects provided fully informed written consent for their participation in the study, and the protocol was approved by the ethics committee of our hospital.
All participants provided information on age, family history, personal habits (alcohol intake, tobacco consumption, type and level of physical exercise, drug ingestion, known pathological conditions) and the duration of the obesity.
Physical examination was conducted to exclude cardiac comorbidities. Height and weight were measured and the BMI was calculated as the weight (kg)/height2 (m2). A 12 lead ECG was obtained. Haematological and biochemical variables were determined from fasting blood samples and included glucose, total cholesterol, triglycerides, high density lipoprotein cholesterol, urea and full blood count. hsCRP was measured using an enzyme-linked immunosorbent assay.
A cross sectional echocardiogram was obtained on all participants (Philips). Echocardiograms were undertaken in our echocardiographic laboratory following standard methods. They included cross sectional, M mode, and Doppler studies. Measurements of LV internal dimensions and wall thicknesses were obtained from two-dimensionally guided M-mode tracings or parasternal long-axis 2-D images according to the American Society of Echocardiography recommendations. 15, 16, 17 Measurements of all variables were made by one observer who was blinded to the patients' clinical details.
Statistical Analysis
Descriptive statistics were done on each of the variables to obtain the frequency distributions. Quantitative variables were described as mean (SD). Comparisons between the obese group and the normal weight group were analysed by t tests. Correlations between clinical variables and left ventricular mass were determined by Spearman correlation. Probability values of p < 0.05 were considered significant.
RESULTS

Baseline Characteristics
No significant differences in age and height between obese and normal groups. Obese subjects had higher weight, body mass index, waist, hip, waist hip ratio, visceral fat, systolic and diastolic blood pressure than normal subjects. There were no significant differences in LVEDD and LVESD between obese and normal group. Obese subjects had higher intraventricular septum, left posterior wall and LV mass than normal subjects.
Correlates of hsCRP
In univariate analysis performed in all obese subjects, hsCRP was significantly correlated with body mass index (r= 0.46, p 0.002; figure 1 ) and visceral fats (r= 0.33, p 0.03; figure 2 ). The correlation between hsCRP and body mass index still significant even in non obese group. Also the correlation between hsCRP and visceral fats in non obese group. hsCRP was not related to LV mass (r=0.29, p 0.06; figure  3A) , but there was a tendency correlate. In the normal group (non obese), the correlation between hsCRP and LV mass was not significant (r= 0.17, p 0.26; figure 3B ). 
DISCUSSION
Sukmoko et al, 9 showed changes in LV structure (LV mass) in obese women who have no other clinically cause of heart disease; left ventricular mass was higher in the obese women than non obese and there was a correlation between visceral fat and left ventricular mass. Wong et al, 18 showed changes in the LV structure and function in healthy subjects with exess weight who have no other clinically appreciable cause of heart disease. These changes appear to Observed Linear related to degree of obesity and some are even present with less severe obesity. These finding differ in a study reported by Iacobellis G, 19 that showed obesity per se, in absence of glucose intolerance, hypertension and dyslipidemia, seem to be not associated with true LV hypertrophy, but severely uncomplicated obese subjects showed greater LV mass and indexed LV mass than normal weight subjects. 20 Another study by Iacobellis et al, 21 showed that insulin resistance in uncomplicated obesity, is associated with an increased LV mass and precocious changes of left ventricular geometry, whereas preserved insulin sensitivity is not associated with increased LV mass.
Inflammation, is associated with the development of atherosclerosis and consequent vascular events. 22 LVH is associated with atherosclerosis. 23 Our data showed that hsCRP is related to body mass index and visceral fat in obese women. The correlation still exist even in non obese women. The correlation between hsCRP and LV mass was not significant in the normal (non obese) women, but there was a tendency correlate in the obese women. Palmieri et al, 14 reported that LVH was associated with higher hsCRP and albuminuria independent of cardiovascular risk factors, including BMI in adults with type 2 diabetes. The hypothesis is that LVH may interact with endothelial dysfunction, cytokines, insulin resistance, and hemodynamics to increased markers of inflammation and albuminuria. Experimental evidence suggests that strechted myocardium is a site of cytokine production. 24 In addition there is evidence in humans that LV hemodynamic overload is associated with increased circulating tumor necrosis factor-α. 25 Hak et al, 26 reported adiposity is strongly associated with CRP in healthy middle aged women and BMI accounted for the relationship between CRP and other variables of the insulin resistance syndrome.
In this study adiposity (BMI and visceral fat) also correlate with hsCRP, but LV mass was not correlate with hsCRP. This result may be influence by obesity per se not LV mass. The discrepancy results from study by Palmieri et al, 14 may be because the populations was difference (diabetes mellitus vs obese). Another reason was the sample in this study was small.
CONCLUSIONS
There was a tendency correlation between hsCRP and LV mass in obese women. This correlations between hsCRP and body mass index/visceral fat were significant. This correlation may be influence by insulin resistance.
